Skip to main content
SpringerLink
Log in

Low Bioavailability of Oral Tacrolimus Suspension in Pediatric Kidney Transplant Patients

  • Research Letter
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bastiaans DE, Cressey TR, Vromans H, Burger DM. The role of formulation on the pharmacokinetics of antiretroviral drugs. Expert Opin Drug Metab Toxicol. 2014;10(7):1019–37. https://doi.org/10.1517/17425255.2014.925879.

    Article  CAS  PubMed  Google Scholar 

  2. Labberton L, Herder RE, Bolhuis MS, Schellekens RCA, Uges DRA. Formulation of a tacrolimus suspension with an extended expiry date in a hospital pharmacy. Eur J Hosp Pharmacy. 2011;17:36–40.

    Google Scholar 

  3. Reding R, Sokal E, Paul K, Janssen M, Evrard V, Wilmotte L, et al. Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients. Pediatr Transplant. 2002;6(2):124–6.

    Article  CAS  Google Scholar 

  4. Bekersky I, Dressler D, Mekki QA. Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol. 2001;41(2):176–82. https://doi.org/10.1177/00912700122009999.

    Article  CAS  PubMed  Google Scholar 

  5. Undre N, Baccarani U, Britz R, Popescu I. Pharmacokinetic profile of prolonged-release tacrolimus when administered via nasogastric tube in de novo liver transplantation: a sub-study of the DIAMOND trial. Ann Transplant. 2019;24:268–72. https://doi.org/10.12659/AOT.909693.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Johnson TN, Tanner MS, Taylor CJ, Tucker GT. Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol. 2001;51(5):451–60.

    Article  CAS  Google Scholar 

  7. Fakhoury M, Litalien C, Medard Y, Cave H, Ezzahir N, Peuchmaur M, et al. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age. Drug Metab Dispos. 2005;33(11):1603–7. https://doi.org/10.1124/dmd.105.005611.

    Article  CAS  PubMed  Google Scholar 

  8. de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 1999;37(6):485–505. https://doi.org/10.2165/00003088-199937060-00004.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Chris Vermaat for the critical review of the manuscript and the information on the production process of the tacrolimus suspension.

Author information

Authors and Affiliations

  1. Department of Pediatric Nephrology, 804, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Amalia Children’s Hospital, PO Box 9101, 6500 HB, Nijmegen, The Netherlands

    Anne M. Schijvens, Elisabeth A. M. Cornelissen, Fransje H. S. van Hesteren & Michiel F. Schreuder

  2. Department of Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands

    Saskia N. de Wildt

  3. Intensive Care and Department of Pediatric Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands

    Saskia N. de Wildt

  4. Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands

    Rob ter Heine

Authors
  1. Anne M. Schijvens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saskia N. de Wildt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabeth A. M. Cornelissen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fransje H. S. van Hesteren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michiel F. Schreuder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rob ter Heine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne M. Schijvens.

Ethics declarations

Funding

This study was funded by the Dutch Kidney Foundation (grant number 15OKG16, M.F. Schreuder).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

The Ethics Committee of the Radboud University Medical Center waived the need for ethical approval according to the Dutch Law on Human Research, as only patient chart data were anonymously collected.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author contributions

Conception and study design: RtH, MS, AS; data acquisition: AS, FH; data analysis/interpretation: all authors. Each author contributed important intellectual content during manuscript drafting or revision, approved the submitted version of the manuscript, accepts personal accountability for the author’s own contributions, and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 437 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schijvens, A.M., de Wildt, S.N., Cornelissen, E.A.M. et al. Low Bioavailability of Oral Tacrolimus Suspension in Pediatric Kidney Transplant Patients. Clin Pharmacokinet 59, 1483–1485 (2020). https://doi.org/10.1007/s40262-020-00908-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40262-020-00908-9

Search

Navigation